 BEVERLY, Mass., Dec. 17, 2020 GLOBE NEWSWIRE -- LexaGene Holdings, Inc., TSX-V: LXG; OTCQB: LXXGF the Company, a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that it will place MiQLabTM systems into the busy clinical practices of two specialty and emergency veterinary hospitals as part of LexaGenes Early Access Program. 